title: Safety and regulatory issues in anabolic agents' use and development.
authors.affiliation: Division of Endocrine and Metabolic Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA.
authors.forename: S
authors.initials: S
authors.lastname: Malozowski
authors.forename: E
authors.initials: E
authors.lastname: Koller
mesh_terms: D002100:Cachexia / Q000188:drug therapy; D006133:Growth Substances / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007880:Legislation, Drug
chemical_list: D006133:Growth Substances